J.-M. L’Orphelin, “NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial”, AO, vol. 63, no. 1, pp. 867–877, Nov. 2024.